8/6/2013

The FDA granted breakthrough therapy status to a total of 25 drugs by the end of July. The emphasis on a special pathway is driving more attention to treatments that exemplify an improvement in the standard of care, Clark Herman writes.

Full Story:
PharmExec.com

Related Summaries